232 related articles for article (PubMed ID: 27696244)
1. In phyllodes tumour of the breast expression of c-kit but not of ALDH1A1 is associated with adverse clinico-pathological features.
Chougule A; Bal A; Das A; Kohli PS; Singh G
Virchows Arch; 2016 Dec; 469(6):651-658. PubMed ID: 27696244
[TBL] [Abstract][Full Text] [Related]
2. Associations of epithelial c-kit expression in phyllodes tumours of the breast.
Tawasil J; Go EM; Tsang JY; Ni YB; Ko CW; Tse GM
J Clin Pathol; 2015 Oct; 68(10):808-11. PubMed ID: 26056158
[TBL] [Abstract][Full Text] [Related]
3. Expression of cancer stem cell markers in breast phyllodes tumor.
Kim SI; Koo JS
Cancer Biomark; 2020; 29(2):235-243. PubMed ID: 32675396
[TBL] [Abstract][Full Text] [Related]
4. Stromal cells in phyllodes tumors of the breast are enriched for EZH2 and stem cell marker expression.
Zhang Y; Liss AL; Chung E; Pierce LJ; Kleer CG
Breast Cancer Res Treat; 2016 Jul; 158(1):21-28. PubMed ID: 27290698
[TBL] [Abstract][Full Text] [Related]
5. p53 expression in phyllodes tumours is associated with histological features of malignancy but does not predict outcome.
Feakins RM; Mulcahy HE; Nickols CD; Wells CA
Histopathology; 1999 Aug; 35(2):162-9. PubMed ID: 10460662
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of homeoproteins Six1 and Pax3 in breast phyllodes tumours correlates with histological grade and clinical outcome.
Tan WJ; Thike AA; Bay BH; Tan PH
Histopathology; 2014 May; 64(6):807-17. PubMed ID: 24438019
[TBL] [Abstract][Full Text] [Related]
7. Phyllodes tumours of the breast: the role of CD34, vascular endothelial growth factor and β-catenin in histological grading and clinical outcome.
Ho SK; Thike AA; Cheok PY; Tse GM; Tan PH
Histopathology; 2013 Sep; 63(3):393-406. PubMed ID: 23772632
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in phyllodes tumours of the breast: retrospective study on 166 consecutive cases.
Di Liso E; Bottosso M; Lo Mele M; Tsvetkova V; Dieci MV; Miglietta F; Falci C; Faggioni G; Tasca G; Giorgi CA; Giarratano T; Mioranza E; Michieletto S; Saibene T; Dei Tos AP; Conte P; Guarneri V
ESMO Open; 2020 Oct; 5(5):e000843. PubMed ID: 33020219
[TBL] [Abstract][Full Text] [Related]
9. C-kit overexpression correlates with KIT gene copy numbers increases in phyllodes tumors of the breast.
Liu J; Liu X; Feng X; Liu J; Lv S; Zhang W; Niu Y
Breast Cancer Res Treat; 2015 Jan; 149(2):395-401. PubMed ID: 25534827
[TBL] [Abstract][Full Text] [Related]
10. 2005 Galloway Memorial Lecture: Breast phyllodes tumours--morphology and beyond.
Tan PH
Ann Acad Med Singap; 2005 Dec; 34(11):671-7. PubMed ID: 16453039
[TBL] [Abstract][Full Text] [Related]
11. Predicting clinical behaviour of breast phyllodes tumours: a nomogram based on histological criteria and surgical margins.
Tan PH; Thike AA; Tan WJ; Thu MM; Busmanis I; Li H; Chay WY; Tan MH;
J Clin Pathol; 2012 Jan; 65(1):69-76. PubMed ID: 22049216
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of epithelial-mesenchymal transition proteins Twist and Foxc2 in phyllodes tumours of the breast.
Lim JC; Koh VC; Tan JS; Tan WJ; Thike AA; Tan PH
Breast Cancer Res Treat; 2015 Feb; 150(1):19-29. PubMed ID: 25677742
[TBL] [Abstract][Full Text] [Related]
13. E-cadherin expression in the epithelial components of mammary phyllodes tumors.
Tsang JY; Mendoza P; Putti TC; Karim RZ; Scolyer RA; Lee CS; Pang AL; Tse GM
Hum Pathol; 2012 Dec; 43(12):2117-23. PubMed ID: 22820000
[TBL] [Abstract][Full Text] [Related]
14. Phyllodes tumors of the breast: clinicopathological analysis of 106 cases from a single institution.
Efared B; Ebang GA; Tahiri L; Sidibé IS; Erregad F; Hammas N; Melhouf MA; Banani A; Chbani L; Fatemi HE
Breast Dis; 2018; 37(3):139-145. PubMed ID: 29332027
[TBL] [Abstract][Full Text] [Related]
15. Recurrent phyllodes tumours of the breast: pathological features and clinical implications.
Tan EY; Tan PH; Yong WS; Wong HB; Ho GH; Yeo AW; Wong CY
ANZ J Surg; 2006 Jun; 76(6):476-80. PubMed ID: 16768772
[TBL] [Abstract][Full Text] [Related]
16. p53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray study.
Tan PH; Jayabaskar T; Yip G; Tan Y; Hilmy M; Selvarajan S; Bay BH
Mod Pathol; 2005 Dec; 18(12):1527-34. PubMed ID: 16258510
[TBL] [Abstract][Full Text] [Related]
17. Endothelin-1 expression correlates with atypical histological features in mammary phyllodes tumours.
Tse GM; Chaiwun B; Lau KM; Scolyer R; Lee CS; Karim RZ; Putti TC; Law BK; Lui PC; Tan PH
J Clin Pathol; 2007 Sep; 60(9):1051-6. PubMed ID: 17158636
[TBL] [Abstract][Full Text] [Related]
18. CD10, actin, and vimentin expression in breast phyllodes tumors correlates with tumor grades of the WHO grading system.
Tsai WC; Jin JS; Yu JC; Sheu LF
Int J Surg Pathol; 2006 Apr; 14(2):127-31. PubMed ID: 16703173
[TBL] [Abstract][Full Text] [Related]
19. CD117 expression in breast phyllodes tumors correlates with adverse pathologic parameters and reduced survival.
Tan WJ; Thike AA; Tan SY; Tse GM; Tan MH; Bay BH; Tan PH
Mod Pathol; 2015 Mar; 28(3):352-8. PubMed ID: 25216225
[TBL] [Abstract][Full Text] [Related]
20. Analysis of phyllodes tumor recurrence according to the histologic grade.
Kim S; Kim JY; Kim DH; Jung WH; Koo JS
Breast Cancer Res Treat; 2013 Oct; 141(3):353-63. PubMed ID: 24062207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
